Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 1,521 shares at $12.00 ($18K) on 2020-04-16, disclosed to the SEC on 2020-04-17.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 500 | $6K | 32.7% |
| 2 | $12.08 | 1,021 | $12K | 67.3% |
| Total | $12.05 avg | 1,521 | $18K | 100% |
| Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |
| HARP | SELL | 2020-03-18 | $18K | — | Filing → |